BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting
Steady2 outlets reported this in 2 reports over 2 days
Fri, 9 October 2026Wed, 14 October 2026
What it is about
Greg FribergBiomarin RareconnectionsKatherine PowellResearch DevelopmentDrug AdministrationExchange CommissionWeek Results From The PivotalNasdaqMineral ResearchAmerican Society For BonePrnewswire Biomarin Pharmaceutical IncBiomarin Pharmaceutical IncEuropean CommissionEuropean Medicines AgencyBoston, Massachusetts, United StatesJapanAmericanAustralia
Who published it, and when
original reportfirst to report
prnewswire.com
theconversation.com
9 Oct, 13:05over 5 days14 Oct, 16:15
How it spread - 2 original reports
Fri, 9 October 2026
1 report- prnewswire.com13:05first to report
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it will present new data from 13 studies at the American Society for Bone and...
Wed, 14 October 2026
1 report- theconversation.com16:15
Treatment for achondroplasia raises a difficult question: should children’s bodies change to overcome barriers that society could remove?